Related Experiment Videos
Demographic, biologic, and other variables affecting monoamine oxidase activity
Schizophrenia Bulletin
|January 1, 1980
Summary
Monoamine oxidase (MAO) activity varies with age, sex, and substance use. While factors like platelet characteristics and neuroleptic treatment complicate studies, brain MAO differences in schizophrenia remain unproven.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Monoamine oxidase (MAO) enzyme activity is influenced by numerous demographic, biological, and external factors.
- Platelet, plasma, and brain MAO activities show correlations with age and are generally higher in females.
- Age-related decreases in brain catecholamines are observed.
Purpose of the Study:
- To review factors influencing monoamine oxidase (MAO) activity.
- To discuss the implications of these factors for clinical research, particularly in schizophrenia.
- To evaluate the current evidence for altered brain MAO activity in schizophrenia.
Main Methods:
- Review of existing literature on monoamine oxidase (MAO) activity.
- Analysis of demographic, biological, and pharmacological influences on MAO.
- Examination of studies investigating MAO activity in schizophrenia.
Main Results:
- MAO activity is affected by age, sex, ethanol consumption (chronic effects), drugs, and hormones.
- Platelet heterogeneity (size, density, age) complicates MAO activity studies.
- Limited studies on brain MAO in schizophrenia show no significant differences compared to controls.
Conclusions:
- Careful control of variables like platelet characteristics and prior neuroleptic treatment is crucial for MAO studies in clinical populations.
- Current evidence does not support differences in brain MAO activity between schizophrenia patients and healthy individuals.
- Further research may benefit from advanced platelet isolation techniques to reduce variability.